LINDA MARQUEZ: Open Payments
NPI 1952827529 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 24 payments from 11 companies in 2025. Trend: 2023 $797 · 2024 $623 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $116 |
| Amgen Inc. | 6 | $106 |
| PFIZER INC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Boston Scientific Corporation | 1 | $40 |
| ABIOMED | 1 | $40 |
| Edwards Lifesciences Corporation | 1 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $30 |
| Mannkind Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: CARDIOMEMS, REPATHA, LEQVIO, ELIQUIS, WATCHMAN FLX, SAPIEN 3 Ultra RESILIA, FUROSCIX, AFREZZA.
Industry payments across IN — which companies pay providers there.
